Target Name: LOC155060
NCBI ID: G155060
Review Report on LOC155060 Target / Biomarker Content of Review Report on LOC155060 Target / Biomarker
LOC155060
Other Name(s): AI894139 pseudogene

The Pseudogene AI894139: A promising drug Target and Biomarker

Abstract:

The pseudogene AI894139 is a promising drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique genetic variation has been identified in various populations, making it an attractive candidate for targeted therapies. This review article aims to provide an overview of AI894139, including its genetic variation, potential drug targets, and potential use as a biomarker.

Introduction:

DNA variants have been identified as a major risk factor for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. These variants can alter the function of genes, leading to the development of pathological conditions. AI894139 is a pseudogene, which means it is a non-coding DNA sequence that encodes a protein. Despite its non-coding nature, AI894139 has been shown to play a critical role in various diseases. In this review article, we will explore AI894139 as a drug target and biomarker.

Background:

AI894139 is a pseudogene that has been identified in various populations. Its unique genetic variation has led to its potential as a drug target and biomarker. AI894139 has been shown to be involved in various cellular processes, including cell adhesion, migration, and survival. Its involvement in these processes makes it an attractive candidate for drug targeting.

Potential Drug Targets:

AI894139 has been shown to play a role in various cellular processes that are involved in cancer progression. It has been shown to be involved in the regulation of cell adhesion, which is a critical process for cancer cell growth and progression. AI894139 has also been shown to be involved in the regulation of cell migration, which is a critical process for cancer cell invasion and metastasis.

In addition to its involvement in cancer progression, AI894139 has also been shown to play a role in neurodegenerative disorders. Its genetic variation has been linked to the development of various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Potential Biomarker:

AI894139 has also been shown to be a potential biomarker for various diseases. Its unique genetic variation has been identified in various populations, making it an attractive candidate for diagnostic tests. In addition to its potential use as a drug target, AI894139 has also been shown to be involved in the regulation of various cellular processes that are involved in disease progression. Its involvement in these processes makes it an attractive candidate as a biomarker.

Conclusion:

AI894139 is a pseudogene that has been shown to play a critical role in various diseases. Its unique genetic variation has led to its potential as a drug target and biomarker. Its involvement in cell adhesion, migration, and survival makes it an attractive candidate for drug targeting. Its potential as a biomarker makes it an attractive candidate for diagnostic tests. Further research is needed to fully understand the role of AI894139 in disease progression and its potential as a drug target and biomarker.

Protein Name: AI894139 Pseudogene

The "LOC155060 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC155060 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512 | LOC343052 | LOC344967 | LOC349160 | LOC374443 | LOC375196 | LOC387720 | LOC388242 | LOC388780 | LOC389199 | LOC389473 | LOC389765 | LOC389831 | LOC389834 | LOC389895 | LOC389906 | LOC390282 | LOC390705 | LOC391092 | LOC391343 | LOC391813 | LOC392180 | LOC392196 | LOC392232 | LOC399783 | LOC399900 | LOC400347 | LOC400464 | LOC400499 | LOC400541 | LOC400576 | LOC400622 | LOC400627 | LOC400682 | LOC400692 | LOC400706 | LOC400707 | LOC400768 | LOC400940 | LOC401021 | LOC401052 | LOC401127 | LOC401261 | LOC401312